bispecific antibodies (ImClone)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebispecific antibodies (ImClone)

Drug Alias Nameanti EGFR/IGFR antibody (ImClone)di-diabody (ImClone)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInsulin-like growth factor I receptor antagonistsEpidermal growth factor receptor erbB1 antagonists

TargetsInsulin-like growth factor I receptorEpidermal growth factor receptor erbB1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImclone Systems

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImclone Systems

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A